Filling the need for trusted information on national health issues…

MSF Releases New Report On DR-TB Treatment, Urges Company To Halve Price Of Newer TB Drug Bedaquiline

Médecins Sans Frontières: High prices restrict access to best drug-resistant tuberculosis treatment
“People with drug-resistant tuberculosis (DR-TB) continue to be deprived of today’s best-possible treatment in part because of high drug prices, according to a new report — DR-TB Drugs Under the Microscope — released [Tuesday] by Médecins Sans Frontières (MSF) at the 49th Union World Conference on Lung Health in The Hague. MSF is calling, in particular, on U.S. pharmaceutical corporation Johnson & Johnson (J&J) to cut the price of the newer TB drug bedaquiline in half, so more lives can be saved…” (10/23).

The Henry J. Kaiser Family Foundation Headquarters: 2400 Sand Hill Road, Menlo Park, CA 94025 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/KaiserFamFound

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in Menlo Park, California.